Adequacy and Efficacy of the e2TM Cervical Cell Collector Compared to Standard Spatula/CytoBrush Technique.

Completed

Conditions studied: Colposcopy, Biopsy

In brief

A clinical study to determine the adequacy and efficacy of the InPath e2TM Collector compared to the FDA-approved spatula/cytobrush when used as the cell collection device in screening for cervical cancer. The InPath e2TM Collector name has been changed to the CytoCore SoftPAP(R) Collector

Key facts

Study ID

NCT00474968

Run by

CytoCore, Inc.

People needed

737

Starts

2007-04-01

Expected to finish

2008-05-01

Last updated by the study team

2009-11-20

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Women ages 18 years old and above
• Women scheduled to undergo colposcopy

You may not qualify if…

• Patients who have had a hysterectomy
• Patients who are pregnant.

Where it is running

• Visions Clinical Research — Wellington, Florida, United States
• Comprehensive Clinical Trials — West Palm Beach, Florida, United States
• St. Louis University — St Louis, Missouri, United States
• University of Cincinnati — Cincinnati, Ohio, United States
• University of Pittsburgh Medical Centers — Pittsburgh, Pennsylvania, United States
• Baylor Research Institute — Fort Worth, Texas, United States
• Eastern Virginia Medical School — Norfolk, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.